Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
0.907
-0.013 (-1.39%)
Nov 21, 2024, 2:05 PM EST - Market open

Microbot Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
4.74.345.775.415.894.37
Upgrade
Research & Development
5.565.517.515.953.22.87
Upgrade
Operating Expenses
10.269.8613.2811.369.097.24
Upgrade
Operating Income
-10.26-9.86-13.28-11.36-9.09-7.24
Upgrade
Interest Expense
-----0.08-0.1
Upgrade
Interest & Investment Income
0.230.230.120.04--
Upgrade
Other Non Operating Income (Expenses)
-0.06-----
Upgrade
EBT Excluding Unusual Items
-10.09-9.63-13.16-11.31-9.17-7.34
Upgrade
Gain (Loss) on Sale of Assets
-0-0-0.01--0.1
Upgrade
Legal Settlements
-1.11-1.11----
Upgrade
Pretax Income
-11.21-10.74-13.17-11.31-9.17-7.25
Upgrade
Net Income
-11.21-10.74-13.17-11.31-9.17-7.25
Upgrade
Net Income to Common
-11.21-10.74-13.17-11.31-9.17-7.25
Upgrade
Shares Outstanding (Basic)
14107774
Upgrade
Shares Outstanding (Diluted)
14107774
Upgrade
Shares Change (YoY)
56.03%40.49%2.14%-0.14%66.80%41.66%
Upgrade
EPS (Basic)
-0.78-1.05-1.81-1.59-1.29-1.70
Upgrade
EPS (Diluted)
-0.78-1.05-1.81-1.59-1.29-1.70
Upgrade
Free Cash Flow
-8.97-8.57-11.63-9.42-7.34-6.67
Upgrade
Free Cash Flow Per Share
-0.63-0.84-1.60-1.33-1.03-1.56
Upgrade
EBITDA
-10.16-9.75-13.18-11.28-9.02-7.16
Upgrade
D&A For EBITDA
0.10.110.10.080.070.08
Upgrade
EBIT
-10.26-9.86-13.28-11.36-9.09-7.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.